VBI Vaccines Balance Sheet Health

Financial Health criteria checks 2/6

VBI Vaccines has a total shareholder equity of $19.9M and total debt of $50.3M, which brings its debt-to-equity ratio to 252.9%. Its total assets and total liabilities are $100.8M and $80.9M respectively.

Key information

252.9%

Debt to equity ratio

US$50.30m

Debt

Interest coverage ration/a
CashUS$35.45m
EquityUS$19.89m
Total liabilitiesUS$80.90m
Total assetsUS$100.78m

Recent financial health updates

Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?

Jun 09
Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?

Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?

Jan 24
Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?

Is VBI Vaccines (NASDAQ:VBIV) Weighed On By Its Debt Load?

Oct 06
Is VBI Vaccines (NASDAQ:VBIV) Weighed On By Its Debt Load?

VBI Vaccines (NASDAQ:VBIV) Has Debt But No Earnings; Should You Worry?

Jul 08
VBI Vaccines (NASDAQ:VBIV) Has Debt But No Earnings; Should You Worry?

Recent updates

VBI Vaccines: Recent Updates Have Fortified My Long-Term Outlook

Sep 22

VBI Vaccines gets up to $100M debt funding from K2 HealthVentures

Sep 15

Valneva, VBI Vaccines in pact to launch Hep B vaccine in Europe

Sep 08

VBI Vaccines down 10% on $300M mixed shelf offering; also ends two equity offerings

Aug 26

VBI Vaccines: Recent VBI-1901 Data Supports My Bull Thesis

Jun 17

Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?

Jun 09
Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?

Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?

Jan 24
Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?

VBI Vaccines: Hepatitis Vaccine Approval Can Be A Catalyst For >$1bn Valuation

Oct 31

Is VBI Vaccines (NASDAQ:VBIV) Weighed On By Its Debt Load?

Oct 06
Is VBI Vaccines (NASDAQ:VBIV) Weighed On By Its Debt Load?

VBI Vaccines: Turning My Focus To VBI-1901

Jul 15

VBI Vaccines (NASDAQ:VBIV) Has Debt But No Earnings; Should You Worry?

Jul 08
VBI Vaccines (NASDAQ:VBIV) Has Debt But No Earnings; Should You Worry?

VBI Vaccines shares rise after FDA grants VBI-1901 'fast track' status

Jun 08

The CEO Of VBI Vaccines Inc. (NASDAQ:VBIV) Might See A Pay Rise On The Horizon

Jun 03
The CEO Of VBI Vaccines Inc. (NASDAQ:VBIV) Might See A Pay Rise On The Horizon

VBI Vaccines EPS misses by $0.01, misses on revenue

May 10

VBI Vaccines reports preclinical VBI-2902 data in COVID-19

Apr 28

Market Sentiment Around Loss-Making VBI Vaccines Inc. (NASDAQ:VBIV)

Mar 30
Market Sentiment Around Loss-Making VBI Vaccines Inc. (NASDAQ:VBIV)

Financial Position Analysis

Short Term Liabilities: VBIV's short term assets ($50.1M) do not cover its short term liabilities ($77.2M).

Long Term Liabilities: VBIV's short term assets ($50.1M) exceed its long term liabilities ($3.7M).


Debt to Equity History and Analysis

Debt Level: VBIV's net debt to equity ratio (74.7%) is considered high.

Reducing Debt: VBIV's debt to equity ratio has increased from 17.7% to 252.9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: VBIV has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: VBIV has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 11.5% each year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.